Tech-enabled drug discovery company Valo Health announced today plans to go public through a $2.8 billion SPAC deal with Khosla Ventures Acquisition Co., a special purpose acquisition company from Khosla Ventures.
The deal, which is expected to close in the third quarter of this year, will deliver approximately $168.5 million in proceeds in private investment in public equity (PIPE) funding from...
